Pharmaceutical and diagnostics giant Roche has recently integrated a suite of AI algorithms into its enterprise digital pathology software.
The company has collaborated with South Korean firm Deep Bio to power the navify digital pathology platform with the prostate cancer analysis AI solution, DeepDx Prostate. The AI technology provides pathologists with gland-level Gleason grading, measurements...
